OPSUMIT for Pulmonary arterial hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 176 adverse event reports in the FDA FAERS database where OPSUMIT was used for Pulmonary arterial hypertension.
Most Reported Side Effects for OPSUMIT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 52 | 15.3% | 5 | 24 |
| Headache | 33 | 9.7% | 1 | 2 |
| Death | 27 | 8.0% | 27 | 6 |
| Nausea | 21 | 6.2% | 2 | 4 |
| Cough | 19 | 5.6% | 1 | 5 |
| Fluid retention | 19 | 5.6% | 2 | 9 |
| Malaise | 19 | 5.6% | 0 | 6 |
| Nasal congestion | 19 | 5.6% | 0 | 2 |
| Pneumonia | 19 | 5.6% | 9 | 15 |
| Oedema peripheral | 17 | 5.0% | 0 | 7 |
| Pulmonary arterial hypertension | 16 | 4.7% | 10 | 10 |
| Disease progression | 14 | 4.1% | 13 | 8 |
| Fatigue | 13 | 3.8% | 0 | 5 |
| Fluid overload | 13 | 3.8% | 4 | 12 |
| Oedema | 13 | 3.8% | 1 | 6 |
Other Indications for OPSUMIT
Product used for unknown indication (73)
Pulmonary hypertension (41)
Cor pulmonale chronic (21)
Connective tissue disorder (7)
Cardiac disorder (6)
Portopulmonary hypertension (6)
Other Drugs Used for Pulmonary arterial hypertension
TREPROSTINIL (72,609)
MACITENTAN (29,246)
AMBRISENTAN (27,852)
BOSENTAN (12,387)
SELEXIPAG (11,861)
RIOCIGUAT (9,158)
EPOPROSTENOL (8,508)
TADALAFIL (7,679)
SILDENAFIL (5,239)
ILOPROST (2,828)